{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T01:26:13Z","timestamp":1791595573532,"version":"4.3.4"},"reference-count":122,"publisher":"MDPI AG","issue":"13","license":[{"start":{"date-parts":[[2023,6,21]],"date-time":"2023-06-21T00:00:00Z","timestamp":1687305600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"National Science Foundation","award":["CHE-2055190"],"award-info":[{"award-number":["CHE-2055190"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancers"],"abstract":"<jats:p>Boron neutron capture therapy (BNCT) is a binary cancer treatment that involves the irradiation of 10B-containing tumors with low-energy neutrons (thermal or epithermal). The alpha particles and recoiling Li nuclei that are produced in the 10B-capture nuclear reaction are high-linear-energy transfer particles that destroy boron-loaded tumor cells; therefore, BNCT has the potential to be a localized therapeutic modality. Two boron-delivery agents have been used in clinical trials of BNCT in patients with malignant brain tumors, cutaneous melanoma, or recurrent tumors of the head and neck region, demonstrating the potential of BNCT in the treatment of difficult cancers. A variety of potentially highly effective boron-delivery agents have been synthesized in the past four decades and tested in cells and animal models. These include boron-containing nucleosides, peptides, proteins, polyamines, porphyrins, liposomes, monoclonal antibodies, and nanoparticles of various types. The most promising agents are multi-functional boronated molecules and nanoparticles functionalized with tumor cell-targeting moieties that increase their tumor selectivity and contain a radiolabel or fluorophore to allow quantification of 10B-biodistribution and treatment planning. This review discusses multi-functional boron agents reported in the last decade, but their full potential can only be ascertained after their evaluation in BNCT clinical trials.<\/jats:p>","DOI":"10.3390\/cancers15133277","type":"journal-article","created":{"date-parts":[[2023,6,22]],"date-time":"2023-06-22T02:09:17Z","timestamp":1687399757000},"page":"3277","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":56,"title":["Multi-Functional Boron-Delivery Agents for Boron Neutron Capture Therapy of Cancers"],"prefix":"10.3390","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0009-0009-8302-9848","authenticated-orcid":false,"given":"Sebastian O.","family":"Oloo","sequence":"first","affiliation":[{"name":"Department of Chemistry, Louisiana State University, Baton Rouge, LA 70803, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6736-4779","authenticated-orcid":false,"given":"Kevin M.","family":"Smith","sequence":"additional","affiliation":[{"name":"Department of Chemistry, Louisiana State University, Baton Rouge, LA 70803, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4429-7868","authenticated-orcid":false,"given":"Maria da Gra\u00e7a H.","family":"Vicente","sequence":"additional","affiliation":[{"name":"Department of Chemistry, Louisiana State University, Baton Rouge, LA 70803, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2023,6,21]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"2389","DOI":"10.1021\/cr980493e","article-title":"The Chemistry of Neutron Capture Therapy","volume":"98","author":"Soloway","year":"1998","journal-title":"Chem. Rev."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"3987","DOI":"10.1158\/1078-0432.CCR-05-0035","article-title":"Boron Neutron Capture Therapy of Cancer: Current Status and Future Prospects","volume":"11","author":"Barth","year":"2005","journal-title":"Clin. Cancer Res."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1186\/1748-717X-7-146","article-title":"Current status of boron neutron capture therapy of high grade gliomas and recurrent head and neck cancer","volume":"7","author":"Barth","year":"2012","journal-title":"Radiat. Oncol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"e67","DOI":"10.1016\/j.ijrobp.2010.09.057","article-title":"Boron Neutron Capture Therapy in the Treatment of Locally Recurred Head-and-Neck Cancer: Final Analysis of a Phase I\/II Trial","volume":"82","author":"Kankaanranta","year":"2012","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1016\/j.apradiso.2011.03.022","article-title":"Boron neutron capture therapy for newly diagnosed glioblastoma multiforme: An assessment of clinical potential","volume":"69","author":"Hopewell","year":"2011","journal-title":"Appl. Radiat. Isot."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.apradiso.2013.11.109","article-title":"Critical review, with an optimistic outlook, on Boron Neutron Capture Therapy (BNCT)","volume":"88","author":"Moss","year":"2014","journal-title":"Appl. Radiat. Isot."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1186\/s40880-018-0280-5","article-title":"A realistic appraisal of boron neutron capture therapy as a cancer treatment modality","volume":"38","author":"Barth","year":"2018","journal-title":"Cancer Commun."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"213139","DOI":"10.1016\/j.ccr.2019.213139","article-title":"Boron agents for neutron capture therapy","volume":"405","author":"Hu","year":"2020","journal-title":"Coord. Chem. Rev."},{"key":"ref_9","unstructured":"Hosmane, N.S. (2011). Boron Science: New Technologies & Applications, CRC Press."},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"Sauerwein, W., Wittig, A., Moss, R., and Nakagawa, Y. (2012). Neutron Capture Therapy, Springer.","DOI":"10.1007\/978-3-642-31334-9"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/s40880-018-0299-7","article-title":"Boron delivery agents for neutron capture therapy of cancer","volume":"38","author":"Barth","year":"2018","journal-title":"Cancer Commun."},{"key":"ref_12","unstructured":"Vinas, C. (2019). Medicinal Chemistry of Boron Compounds, Wiley Publishers."},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Ali, F., Hosmane, N.S., and Zhu, Y. (2020). Boron Chemistry for Medical Applications. Molecules, 25.","DOI":"10.3390\/molecules25040828"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"14335","DOI":"10.1002\/chem.202002963","article-title":"Bimodal Therapeutic Agents Against Glioblastoma, One of the Most Lethal Forms of Cancer","volume":"26","author":"Couto","year":"2020","journal-title":"Chem. A Eur. J."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"16266","DOI":"10.1039\/D0RA01522A","article-title":"Ruthenium carboranyl complexes with 2,2\u2032-bipyridine derivatives for potential bimodal therapy application","volume":"10","author":"Teixeira","year":"2020","journal-title":"RSC Adv."},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Kondo, N., Hirano, F., and Temma, T. (2022). Evaluation of 3-Borono-l-Phenylalanine as a Water-Soluble Boron Neutron Capture Therapy Agent. Pharmaceutics, 14.","DOI":"10.3390\/pharmaceutics14051106"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"6604","DOI":"10.1021\/jm8007745","article-title":"Synthesis and Evaluation of Novel Boron-Containing Complexes of Potential Use for the Selective Treatment of Malignant Melanoma","volume":"51","author":"Bonjoch","year":"2008","journal-title":"J. Med. Chem."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.apradiso.2013.11.133","article-title":"Evaluation of unnatural cyclic amino acids as boron delivery agents for treatment of melanomas and gliomas","volume":"88","author":"Barth","year":"2014","journal-title":"Appl. Radiat. Isot."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.biomaterials.2015.03.061","article-title":"Tumor-specific delivery of BSH-3R for boron neutron capture therapy and positron emission tomography imaging in a mouse brain tumor model","volume":"56","author":"Iguchi","year":"2015","journal-title":"Biomaterials"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"3396","DOI":"10.1016\/j.biomaterials.2013.12.055","article-title":"The acceleration of boron neutron capture therapy using multi-linked mercaptoundecahydrododecaborate (BSH) fused cell-penetrating peptide","volume":"35","author":"Michiue","year":"2014","journal-title":"Biomaterials"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"13955","DOI":"10.1039\/C9CC03924D","article-title":"Intracellular target delivery of cell-penetrating peptide-conjugated dodecaborate for boron neutron capture therapy (BNCT)","volume":"55","author":"Nakase","year":"2019","journal-title":"Chem. Commun."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"e24171","DOI":"10.1002\/pep2.24171","article-title":"Targeting of peptide-binding receptors on cancer cells with peptide-drug conjugates","volume":"112","author":"Worm","year":"2020","journal-title":"Pept. Sci."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"571","DOI":"10.3389\/fchem.2020.00571","article-title":"Peptide-Drug Conjugates and Their Targets in Advanced Cancer Therapies","volume":"8","author":"Hoppenz","year":"2020","journal-title":"Front. Chem."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1016\/j.bmc.2011.01.020","article-title":"Synthesis and evaluation of cyclic RGD-boron cluster conjugates to develop tumor-selective boron carriers for boron neutron capture therapy","volume":"19","author":"Kimura","year":"2011","journal-title":"Bioorganic Med. Chem."},{"key":"ref_25","first-page":"103","article-title":"Evaluating the Usefulness of a Novel 10B-Carrier Conjugated With Cyclic RGD Peptide in Boron Neutron Capture Therapy","volume":"3","author":"Masunaga","year":"2012","journal-title":"World J. Oncol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"3740","DOI":"10.1021\/acs.molpharmaceut.0c00478","article-title":"Cyclic RGD-Functionalized closo-Dodecaborate Albumin Conjugates as Integrin Targeting Boron Carriers for Neutron Capture Therapy","volume":"17","author":"Kawai","year":"2020","journal-title":"Mol. Pharm."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"2358","DOI":"10.1021\/acs.jmedchem.9b01136","article-title":"Selective Neuropeptide Y Conjugates with Maximized Carborane Loading as Promising Boron Delivery Agents for Boron Neutron Capture Therapy","volume":"63","author":"Worm","year":"2019","journal-title":"J. Med. Chem."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1446","DOI":"10.1021\/acs.joc.9b02406","article-title":"A Selective Carborane-Functionalized Gastrin-Releasing Peptide Receptor Agonist as Boron Delivery Agent for Boron Neutron Capture Therapy","volume":"85","author":"Hoppenz","year":"2019","journal-title":"J. Org. Chem."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1158\/1078-0432.CCR-07-1968","article-title":"Molecular Targeting and Treatment of Composite EGFR and EGFRvIII-Positive Gliomas Using Boronated Monoclonal Antibodies","volume":"14","author":"Yang","year":"2008","journal-title":"Clin. Cancer Res."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"S328","DOI":"10.1016\/j.apradiso.2009.03.030","article-title":"Boron neutron capture therapy of EGFR or EGFRvIII positive gliomas using either boronated monoclonal antibodies or epidermal growth factor as molecular targeting agents","volume":"67","author":"Yang","year":"2009","journal-title":"Appl. Radiat. Isot."},{"key":"ref_31","unstructured":"Kadish, K.M., Smith, K.M., and Guilard, R. (2000). The Porphyrin Handbook, Elsevier."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/S1556-0864(15)31616-6","article-title":"Photodynamic Therapy (PDT) for Lung Cancers","volume":"1","author":"Usuda","year":"2006","journal-title":"J. Thorac. Oncol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1002\/chem.200901532","article-title":"Boron-Containing Protoporphyrin IX Derivatives and Their Modification for Boron Neutron Capture Therapy: Synthesis, Characterization, and Comparative In Vitro Toxicity Evaluation","volume":"16","author":"Ban","year":"2010","journal-title":"Chem. A Eur. J."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.ijrobp.2005.05.030","article-title":"Toxicity, biodistribution, and convection-enhanced delivery of the boronated porphyrin BOPP in the 9L intracerebral rat glioma model","volume":"63","author":"Ozawa","year":"2005","journal-title":"Int. J. Radiat. Oncol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"2247","DOI":"10.1016\/0040-4039(90)80197-T","article-title":"Preparation of carboranyl porphyrins for boron neutron capture therapy","volume":"31","author":"Miura","year":"1990","journal-title":"Tetrahedron Lett."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1562\/2005-04-04-RA-474","article-title":"Outcome of mTHPC Mediated Photodynamic Therapy is Primarily Determined by the Vascular Response","volume":"81","author":"Triesscheijn","year":"2005","journal-title":"Photochem. Photobiol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"611","DOI":"10.3109\/09553002.2013.782446","article-title":"Microlocalization of lipophilic porphyrins: Non-toxic enhancers of boron neutron-capture therapy","volume":"89","author":"Smilowitz","year":"2013","journal-title":"Int. J. Radiat. Biol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.jphotobiol.2007.09.012","article-title":"Tumour-localizing and -photosensitising properties of meso-tetra(4-nido-carboranylphenyl)porphyrin (H2TCP)","volume":"89","author":"Fabris","year":"2007","journal-title":"J. Photochem. Photobiol. B: Biol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"S321","DOI":"10.1016\/j.apradiso.2009.03.071","article-title":"A novel boronated-porphyrin as a radio-sensitizing agent for boron neutron capture therapy of tumours: In vitro and in vivo studies","volume":"67","author":"Jori","year":"2009","journal-title":"Appl. Radiat. Isot."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1016\/j.bmc.2004.12.016","article-title":"Synthesis and cellular studies of an octa-anionic 5,10,15,20-tetra[3,5-(nido-carboranylmethyl)phenyl]porphyrin (H2OCP) for application in BNCT","volume":"13","author":"Gottumukkala","year":"2005","journal-title":"Bioorganic Med. Chem."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"9035","DOI":"10.1002\/chem.200700752","article-title":"Synthesis, Aggregation and Cellular Investigations of Porphyrin\u2013Cobaltacarborane Conjugates","volume":"13","author":"Hao","year":"2007","journal-title":"Chem. A Eur. J."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1142\/S1088424611003902","article-title":"Synthesis and toxicity of cobaltabisdicarbollide-containing porphyrins of high boron content","volume":"15","author":"Bhupathiraju","year":"2011","journal-title":"J. Porphyrins Phthalocyanines"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1021\/bc060047v","article-title":"Enhanced Cellular Uptake with a Cobaltacarborane\u2212Porphyrin\u2212HIV-1 Tat 48\u221260 Conjugate","volume":"17","author":"Hao","year":"2006","journal-title":"Bioconjugate Chem."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"6718","DOI":"10.1021\/jm500786c","article-title":"Synthesis and in Vitro Evaluation of BBB Permeability, Tumor Cell Uptake, and Cytotoxicity of a Series of Carboranylporphyrin Conjugates","volume":"57","author":"Bhupathiraju","year":"2014","journal-title":"J. Med. Chem."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1002\/jps.24317","article-title":"Tetrakis(p-Carboranylthio-Tetrafluorophenyl)Chlorin (TPFC): Application for Photodynamic Therapy and Boron Neutron Capture Therapy","volume":"104","author":"Hiramatsu","year":"2015","journal-title":"J. Pharm. Sci."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"187","DOI":"10.2174\/1568011023354137","article-title":"Porphyrins in Photodynamic Therapy\u2014A Search for Ideal Photosensitizers","volume":"2","author":"Pushpan","year":"2002","journal-title":"Curr. Med. Chem. Agents"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1002\/lsm.20354","article-title":"Endobronchial photodynamic therapy for lung cancer","volume":"38","author":"Loewen","year":"2006","journal-title":"Lasers Surg. Med."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1562\/0031-8655(2002)0760438PSINCP2.0.CO2","article-title":"Preclinical Studies in Normal Canine Prostate of a Novel Palladium-Bacteriopheophorbide (WST09) Photosensitizer for Photodynamic Therapy of Prostate Cancer","volume":"76","author":"Chen","year":"2007","journal-title":"Photochem. Photobiol."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"1952","DOI":"10.1134\/S1070363219090354","article-title":"Chemical Transformations of Chlorophyll a and Possible Areas for Application of Its Derivatives","volume":"89","author":"Mironov","year":"2019","journal-title":"Russ. J. Gen. Chem."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"639","DOI":"10.2174\/1871520611313040012","article-title":"Differential Binding Preference of Methylpheophorbide a and its Diboronated derivatives to Albumin and low density Lipoproteins","volume":"13","author":"Golovina","year":"2013","journal-title":"Anti Cancer Agents Med. Chem."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1007\/s11172-010-0065-8","article-title":"Synthesis of cobalt bis(dicarbollide) conjugates with natural chlorins by the Sonogashira reaction","volume":"59","author":"Grin","year":"2010","journal-title":"Russ. Chem. Bull."},{"key":"ref_52","doi-asserted-by":"crossref","unstructured":"Volovetsky, A.B., Sukhov, V.S., Balalaeva, I.V., Dudenkova, V.V., Shilyagina, N.Y., Feofanov, V., Efremenko, A.V., Grin, M.A., Mironov, A.F., and Sivaev, I.B. (2017). Pharmacokinetics of Chlorin e6-Cobalt Bis(Dicarbollide) Conjugate in Balb\/c Mice with Engrafted Carcinoma. Int. J. Mol. Sci., 18.","DOI":"10.3390\/ijms18122556"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"817","DOI":"10.3390\/ma6030817","article-title":"Dye Sensitizers for Photodynamic Therapy","volume":"6","author":"Ormond","year":"2013","journal-title":"Materials"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1002\/cplu.201800560","article-title":"A Phthalocyanine-ortho-Carborane Conjugate for Boron Neutron Capture Therapy: Synthesis, Physicochemical Properties, and in vitro Tests","volume":"84","author":"Nar","year":"2019","journal-title":"Chempluschem"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"11021","DOI":"10.1039\/C5DT00394F","article-title":"Water-soluble carboranyl-phthalocyanines for BNCT. Synthesis, characterization, and in vitro tests of the Zn(ii)-nido-carboranyl-hexylthiophthalocyanine","volume":"44","author":"Pietrangeli","year":"2015","journal-title":"Dalton Trans."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"S97","DOI":"10.1016\/j.apradiso.2009.03.023","article-title":"Neutral and polyanionic carboranylporphyrazines: Synthesis and physico-chemical properties","volume":"67","author":"Pietrangeli","year":"2009","journal-title":"Appl. Radiat. Isot."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"181","DOI":"10.7150\/thno.5984","article-title":"Lewis Acid-Assisted Isotopic 18F-19F Exchange in BODIPY Dyes: Facile Generation of Positron Emission Tomography\/Fluorescence Dual Modality Agents for Tumor Imaging","volume":"3","author":"Liu","year":"2013","journal-title":"Theranostics"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.jorganchem.2015.05.009","article-title":"Synthesis and properties of a series of carboranyl-BODIPYs","volume":"798","author":"Gibbs","year":"2015","journal-title":"J. Organomet. Chem."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"2109","DOI":"10.1021\/acs.jmedchem.5b01783","article-title":"Synthesis and in Vitro Studies of a Series of Carborane-Containing Boron Dipyrromethenes (BODIPYs)","volume":"59","author":"Xuan","year":"2016","journal-title":"J. Med. Chem."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.colsurfb.2014.09.029","article-title":"Liposomes as carriers of hydrophilic small molecule drugs: Strategies to enhance encapsulation and delivery","volume":"123","author":"Eloy","year":"2014","journal-title":"Colloids Surf. B Biointerfaces"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1021\/ar200105p","article-title":"Liposomes: From a Clinically Established Drug Delivery System to a Nanoparticle Platform for Theranostic Nanomedicine","volume":"44","author":"Kostarelos","year":"2011","journal-title":"Acc. Chem. Res."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.bpc.2019.01.003","article-title":"Liposome formulations of o-carborane for the boron neutron capture therapy of cancer","volume":"247","author":"Olusanya","year":"2019","journal-title":"Biophys. Chem."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/S0076-6879(09)65010-2","article-title":"Liposomal Boron Delivery for Neutron Capture Therapy","volume":"Volume 465","author":"Nakamura","year":"2009","journal-title":"Methods in Enzymology"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.5650\/jos.ess19218","article-title":"Polyborane-encapsulated PEGylated Liposomes Prepared Using Post-insertion Technique for Boron Neutron Capture Therapy","volume":"68","author":"Takeuchi","year":"2019","journal-title":"J. Oleo Sci."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.jconrel.2005.03.005","article-title":"Transport of nerve growth factor encapsulated into liposomes across the blood\u2013brain barrier: In vitro and in vivo studies","volume":"105","author":"Xie","year":"2005","journal-title":"J. Control. Release"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"2612","DOI":"10.1038\/s41467-018-05035-5","article-title":"Peptide density targets and impedes triple negative breast cancer metastasis","volume":"9","author":"Liu","year":"2018","journal-title":"Nat. Commun."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/j.bbrc.2019.11.144","article-title":"PEGylated liposome encapsulating nido-carborane showed significant tumor suppression in boron neutron capture therapy (BNCT)","volume":"522","author":"Lee","year":"2020","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/j.ijpharm.2011.12.019","article-title":"Predicting hydrophilic drug encapsulation inside unilamellar liposomes","volume":"423","author":"Xu","year":"2012","journal-title":"Int. J. Pharm."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1073\/pnas.96.1.238","article-title":"Toward a cancer therapy with boron-rich oligomeric phosphate diesters that target the cell nucleus","volume":"96","author":"Nakanishi","year":"1999","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"3125","DOI":"10.21873\/invivo.12607","article-title":"Suppression of Tumor Growth in a Rabbit Hepatic Cancer Model by Boron Neutron Capture Therapy With Liposomal Boron Delivery Systems","volume":"35","author":"Yanagie","year":"2021","journal-title":"In Vivo"},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1023\/A:1010960900254","article-title":"Liposomes Bearing Polyethyleneglycol-Coupled Transferrin with Intracellular Targeting Property to the Solid Tumors In Vivo","volume":"18","author":"Ishida","year":"2001","journal-title":"Pharm. Res."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1007\/s10895-020-02637-5","article-title":"In Vitro and In Vivo Evaluation of Fluorescently Labeled Borocaptate-Containing Liposomes","volume":"31","author":"Kanygin","year":"2021","journal-title":"J. Fluoresc."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.ijpharm.2014.10.045","article-title":"Monoclonal antibody-targeted PEGylated liposome-ICG encapsulating doxorubicin as a potential theranostic agent","volume":"482","author":"Lozano","year":"2015","journal-title":"Int. J. Pharm."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.jconrel.2014.06.046","article-title":"PEG\u2014A versatile conjugating ligand for drugs and drug delivery systems","volume":"192","author":"Kolate","year":"2014","journal-title":"J. Control. Release"},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1080\/09553002.2020.1761039","article-title":"Accelerator-based boron neutron capture therapy for malignant glioma: A pilot neutron irradiation study using boron phenylalanine, sodium borocaptate and liposomal borocaptate with a heterotopic U87 glioblastoma model in SCID mice","volume":"96","author":"Zavjalov","year":"2020","journal-title":"Int. J. Radiat. Biol."},{"key":"ref_76","doi-asserted-by":"crossref","unstructured":"Matsumura, Y., and Tarin, D. (2019). Cancer Drug Delivery Systems Based on the Tumor Microenvironment, Springer.","DOI":"10.1007\/978-4-431-56880-3"},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1080\/09553000500332137","article-title":"EGF-receptor targeted liposomes with boronated acridine: Growth inhibition of cultured glioma cells after neutron irradiation","volume":"81","author":"Kullberg","year":"2005","journal-title":"Int. J. Radiat. Biol."},{"key":"ref_78","first-page":"1159","article-title":"Trastuzumab-conjugated boron-containing liposomes for tumor-cell targeting; development and cellular studies","volume":"23","author":"Wei","year":"2003","journal-title":"Int. J. Oncol."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1126\/science.281.5373.78","article-title":"An Inverted Hexagonal Phase of Cationic Liposome-DNA Complexes Related to DNA Release and Delivery","volume":"281","author":"Koltover","year":"1998","journal-title":"Science"},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1529\/biophysj.104.049080","article-title":"Structural Characterization of Cationic Liposomes Loaded with Sugar-Based Carboranes","volume":"88","author":"Ristori","year":"2005","journal-title":"Biophys. J."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"7829","DOI":"10.1021\/jm900763b","article-title":"Carborane Derivatives Loaded into Liposomes as Efficient Delivery Systems for Boron Neutron Capture Therapy","volume":"52","author":"Altieri","year":"2009","journal-title":"J. Med. Chem."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"2143","DOI":"10.1038\/s41467-022-29780-w","article-title":"Boron encapsulated in a liposome can be used for combinational neutron capture therapy","volume":"13","author":"Li","year":"2022","journal-title":"Nat. Commun."},{"key":"ref_83","doi-asserted-by":"crossref","unstructured":"Ailuno, G., Balboni, A., Caviglioli, G., Lai, F., Barbieri, F., Dellacasagrande, I., Florio, T., and Baldassari, S. (2022). Boron Vehiculating Nanosystems for Neutron Capture Therapy in Cancer Treatment. Cells, 11.","DOI":"10.3390\/cells11244029"},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1016\/j.reactfunctpolym.2011.03.010","article-title":"Carborane confined nanoparticles for boron neutron capture therapy: Improved stability, blood circulation time and tumor accumulation","volume":"71","author":"Sumitani","year":"2011","journal-title":"React. Funct. Polym."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1002\/cac2.12089","article-title":"Boron neutron capture therapy: Current status and future perspectives","volume":"40","author":"Dymova","year":"2020","journal-title":"Cancer Commun."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1134\/S0012500820030027","article-title":"Elemental Boron Nanoparticles: Production by Ultrasonication in Aqueous Medium and Application in Boron Neutron Capture Therapy","volume":"491","author":"Uspenskii","year":"2020","journal-title":"Dokl. Chem."},{"key":"ref_87","doi-asserted-by":"crossref","unstructured":"Zaboronok, A., Khaptakhanova, P., Uspenskii, S., Bekarevich, R., Mechetina, L., Volkova, O., Mathis, B.J., Kanygin, V., Ishikawa, E., and Kasatova, A. (2022). Polymer-Stabilized Elemental Boron Nanoparticles for Boron Neutron Capture Therapy: Initial Irradiation Experiments. Pharmaceutics, 14.","DOI":"10.3390\/pharmaceutics14040761"},{"key":"ref_88","doi-asserted-by":"crossref","unstructured":"Kaniowski, D., Ebenryter-Olbi\u0144ska, K., Kulik, K., Suwara, J., Cypryk, W., Jak\u00f3bik-Kolon, A., Le\u015bnikowski, Z., and Nawrot, B. (2021). Composites of Nucleic Acids and Boron Clusters (C2B10H12) as Functional Nanoparticles for Downregulation of EGFR Oncogene in Cancer Cells. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22094863"},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"2313","DOI":"10.1007\/s11051-010-9911-8","article-title":"Toxicity and cellular uptake of gold nanoparticles: What we have learned so far?","volume":"12","author":"Alkilany","year":"2010","journal-title":"J. Nanoparticle Res."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"5054","DOI":"10.1039\/C3DT52872C","article-title":"Preparation and characterization of Au nanoparticles capped with mercaptocarboranyl clusters","volume":"43","author":"Cioran","year":"2014","journal-title":"Dalton Trans."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.cossms.2012.09.001","article-title":"Multifunctional nanocarriers and intracellular drug delivery","volume":"16","author":"Sawant","year":"2012","journal-title":"Curr. Opin. Solid State Mater. Sci."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"110387","DOI":"10.1016\/j.colsurfb.2019.110387","article-title":"Development of theranostic active-targeting boron-containing gold nanoparticles for boron neutron capture therapy (BNCT)","volume":"183","author":"Wu","year":"2019","journal-title":"Colloids Surf. B Biointerfaces"},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1021\/acs.biomac.6b01845","article-title":"Carborane Derivative Conjugated with Gold Nanoclusters for Targeted Cancer Cell Imaging","volume":"18","author":"Wang","year":"2017","journal-title":"Biomacromolecules"},{"key":"ref_94","doi-asserted-by":"crossref","unstructured":"Popova, T.V., Pyshnaya, I.A., Zakharova, O.D., Akulov, A.E., Shevelev, O.B., Poletaeva, J., Zavjalov, E.L., Silnikov, V.N., Ryabchikova, E.I., and Godovikova, T.S. (2021). Rational Design of Albumin Theranostic Conjugates for Gold Nanoparticles Anticancer Drugs: Where the Seed Meets the Soil?. Biomedicines, 9.","DOI":"10.3390\/biomedicines9010074"},{"key":"ref_95","doi-asserted-by":"crossref","unstructured":"Wu, C.-Y., Hsieh, H.-H., Chang, T.-Y., Lin, J.-J., Wu, C.-C., Hsu, M.-H., Lin, M.-C., and Peng, S.-L. (2021). Development of MRI-Detectable Boron-Containing Gold Nanoparticle-Encapsulated Biodegradable Polymeric Matrix for Boron Neutron Capture Therapy (BNCT). Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22158050"},{"key":"ref_96","doi-asserted-by":"crossref","unstructured":"Pulagam, K.R., Gona, K.B., G\u00f3mez-Vallejo, V., Meijer, J., Zilberfain, C., Estrela-Lopis, I., Baz, Z., Coss\u00edo, U., and Llop, J. (2019). Gold Nanoparticles as Boron Carriers for Boron Neutron Capture Therapy: Synthesis, Radiolabelling and In Vivo Evaluation. Molecules, 24.","DOI":"10.3390\/molecules24193609"},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"49589","DOI":"10.1021\/acsami.0c17575","article-title":"In Vivo Evaluation of Multifunctional Gold Nanorods for Boron Neutron Capture and Photothermal Therapies","volume":"13","author":"Pulagam","year":"2021","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"ref_98","doi-asserted-by":"crossref","unstructured":"Sauerwein, W.A.G., Sancey, L., Hey-Hawkins, E., Kellert, M., Panza, L., Imperio, D., Balcerzyk, M., Rizzo, G., Scalco, E., and Herrmann, K. (2021). Theranostics in Boron Neutron Capture Therapy. Life, 11.","DOI":"10.3390\/life11040330"},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1002\/wnan.1311","article-title":"Open challenges in magnetic drug targeting","volume":"7","author":"Shapiro","year":"2015","journal-title":"WIREs Nanomed. Nanobiotechnology"},{"key":"ref_100","unstructured":"Clemons, T.D., Kerr, R.H., and Joos, A. (2019). Comprehensive Nanoscience and Nanotechnology, Elsevier."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"e2001632","DOI":"10.1002\/adhm.202001632","article-title":"Biocompatible Iron\u2013Boron Nanoparticles Designed for Neutron Capture Therapy Guided by Magnetic Resonance Imaging","volume":"10","author":"Torresan","year":"2021","journal-title":"Adv. Health Mater."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"1098765","DOI":"10.1155\/2017\/1098765","article-title":"Use of Magnetic Nanoparticles as Targeted Therapy: Theranostic Approach to Treat and Diagnose Cancer","volume":"2017","author":"Malik","year":"2017","journal-title":"J. Nanotechnol."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1016\/j.jallcom.2018.10.164","article-title":"Preparation of flower-dewdrops Fe3O4\/carbon-SiO2 microsphere for microwave-triggered drug delivery","volume":"775","author":"Yang","year":"2019","journal-title":"J. Alloys Compd."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.jallcom.2017.12.028","article-title":"PEG mediated shape-selective synthesis of cubic Fe3O4 nanoparticles for cancer therapeutics","volume":"737","author":"Dutta","year":"2018","journal-title":"J. Alloys Compd."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"101247","DOI":"10.1016\/j.mtcomm.2020.101247","article-title":"Carboranes immobilization on Fe3O4 nanocomposites for targeted delivery","volume":"24","author":"Korolkov","year":"2020","journal-title":"Mater. Today Commun."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"2771","DOI":"10.1039\/D0QM00867B","article-title":"Carborane based mesoporous nanoparticles as a potential agent for BNCT","volume":"5","author":"Wang","year":"2021","journal-title":"Mater. Chem. Front."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"102195","DOI":"10.1016\/j.nano.2020.102195","article-title":"Functionalized mesoporous silica nanoparticles for innovative boron-neutron capture therapy of resistant cancers","volume":"27","author":"Vares","year":"2020","journal-title":"Nanomed. Nanotechnol. Biol. Med."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"1700850","DOI":"10.1002\/adma.201700850","article-title":"Engineering Novel Targeted Boron-10-Enriched Theranostic Nanomedicine to Combat against Murine Brain Tumors via MR Imaging-Guided Boron Neutron Capture Therapy","volume":"29","author":"Kuthala","year":"2017","journal-title":"Adv. Mater."},{"key":"ref_109","doi-asserted-by":"crossref","unstructured":"Jorio, A., Dresselhaus, G., and Dresselhaus, M.S. (2008). Carbon Nanotubes: Advanced Topics in the Synthesis, Structure, Properties, and Applications, Springer. Topics in applied physics.","DOI":"10.1007\/978-3-540-72865-8"},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1126\/science.1222453","article-title":"Carbon nanotubes: Present and future commercial applications","volume":"339","author":"Tawfick","year":"2013","journal-title":"Science"},{"key":"ref_111","doi-asserted-by":"crossref","unstructured":"Hey-Hawkins, E., and Teixidor, C.V. (2018). Boron-Based Compounds, John Wiley & Sons, Ltd.","DOI":"10.1002\/9781119275602"},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"2413","DOI":"10.1002\/adma.200700179","article-title":"Boron Nitride Nanotubes","volume":"19","author":"Golberg","year":"2007","journal-title":"Adv. Mater."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1007\/s11671-008-9210-9","article-title":"Folate Functionalized Boron Nitride Nanotubes and their Selective Uptake by Glioblastoma Multiforme Cells: Implications for their Use as Boron Carriers in Clinical Boron Neutron Capture Therapy","volume":"4","author":"Ciofani","year":"2009","journal-title":"Nanoscale Res. Lett."},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1016\/j.ijpharm.2012.06.037","article-title":"Transferrin-conjugated boron nitride nanotubes: Protein grafting, characterization, and interaction with human endothelial cells","volume":"436","author":"Ciofani","year":"2012","journal-title":"Int. J. Pharm."},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.bmcl.2014.12.005","article-title":"Antitumor effect of boron nitride nanotubes in combination with thermal neutron irradiation on BNCT","volume":"25","author":"Nakamura","year":"2015","journal-title":"Bioorganic Med. Chem. Lett."},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/j.nano.2013.10.003","article-title":"Biocompatibility of functionalized boron phosphate (BPO4) nanoparticles for boron neutron capture therapy (BNCT) application","volume":"10","author":"Achilli","year":"2014","journal-title":"Nanomed. Nanotechnol. Biol. Med."},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"121861","DOI":"10.1016\/j.biomaterials.2022.121861","article-title":"One step synthesis of 10B-enriched 10BPO4 nanoparticles for effective boron neutron capture therapeutic treatment of recurrent head-and-neck tumor","volume":"290","author":"Kuthala","year":"2022","journal-title":"Biomaterials"},{"key":"ref_118","doi-asserted-by":"crossref","unstructured":"Chiang, C.-W., Chien, Y.-C., Yu, W.-J., Ho, C.-Y., Wang, C.-Y., Wang, T.-W., Chiang, C.-S., and Keng, P.-Y. (2021). Polymer-Coated Nanoparticles for Therapeutic and Diagnostic Non-10B Enriched Polymer-Coated Boron Carbon Oxynitride (BCNO) Nanoparticles as Potent BNCT Drug. Nanomaterials, 11.","DOI":"10.3390\/nano11112936"},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"100162","DOI":"10.1016\/j.giant.2023.100162","article-title":"Investigating the electrostatic complexation of BCNO nanoparticles with a stimuli-responsive double hydrophilic graft copolymer","volume":"14","author":"Chien","year":"2023","journal-title":"Giant"},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1016\/j.matt.2023.01.012","article-title":"Exosome membrane-coated nanosystems: Exploring biomedical applications in cancer diagnosis and therapy","volume":"6","author":"Shao","year":"2023","journal-title":"Matter"},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"2100969","DOI":"10.1002\/adfm.202100969","article-title":"Exosome-Coated 10 B Carbon Dots for Precise Boron Neutron Capture Therapy in a Mouse Model of Glioma In Situ","volume":"31","author":"Li","year":"2021","journal-title":"Adv. Funct. Mater."},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"101558","DOI":"10.1016\/j.nantod.2022.101558","article-title":"Multifunctional high boron content MOFs nano-co-crystals for precise boron neutron capture therapy for brain glioma in situ","volume":"45","author":"Wang","year":"2022","journal-title":"Nano Today"}],"container-title":["Cancers"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2072-6694\/15\/13\/3277\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T19:58:11Z","timestamp":1760126291000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2072-6694\/15\/13\/3277"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6,21]]},"references-count":122,"journal-issue":{"issue":"13","published-online":{"date-parts":[[2023,7]]}},"alternative-id":["cancers15133277"],"URL":"https:\/\/doi.org\/10.3390\/cancers15133277","relation":{},"ISSN":["2072-6694"],"issn-type":[{"value":"2072-6694","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,6,21]]}}}